Modifying effect of gender on the prognostic value of clinicopathological factors and Ki67 expression in melanoma: A population-based cohort study

Biology of Sex Differences

Volumn 3, Issue 1, 2012, Pages

  Fridberg, Marie ^a   Jonsson, Liv ^a   Bergman, Julia ^b   Nodin, Björn ^a   Jirström, Karin ^a  

^a LUND UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Clinicopathological characteristics; Malignant melanoma; Prognosis; Sex

Indexed keywords

EID: 84865784625     PISSN: None     EISSN: 20426410     Source Type: Journal    
DOI: 10.1186/2042-6410-3-16     Document Type: Article

References (34)

1. MacKie RM, Hauschild A, Eggermont AM: Epidemiology of invasive cutaneous melanoma. Ann Oncol 2009, 20(Suppl 6):vi1-vi7.
2. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM, et al: Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001, 19(16):3622-3634. (Pubitemid 32786275)
3. Lee ML, Tomsu K, Von Eschen KB: Duration of survival for disseminated malignant melanoma: results of a meta-analysis. Melanoma Res 2000, 10(1):81-92. (Pubitemid 30127833)
4. Gimotty PA, Elder DE, Fraker DL, Botbyl J, Sellers K, Elenitsas R, Ming ME, Schuchter L, Spitz FR, Czerniecki BJ, et al: Identification of high-risk patients among those diagnosed with thin cutaneous melanomas. J Clin Oncol 2007, 25(9):1129-1134. (Pubitemid 46596766)
5. Lindholm C, Andersson R, Dufmats M, Hansson J, Ingvar C, Moller T, Sjodin H, Stierner U, Wagenius G: Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors. Cancer 2004, 101(9):2067-2078. (Pubitemid 39425384)
6. McKinnon JG, Yu XQ, McCarthy WH, Thompson JF: Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit. Cancer 2003, 98(6):1223-1231. (Pubitemid 37099907)
7. Sondak VK, Messina JL: Current status of biomarkers for melanoma metastasis. IDrugs 2006, 9(9):627-631. (Pubitemid 44382780)
8. Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, et al: Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst 2006, 98(7):472-482.
9. Jonsson G, Busch C, Knappskog S, Geisler J, Miletic H, Ringner M, Lillehaug JR, Borg A, Lonning PE: Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome. Clin Cancer Res 2010, 16(13):3356-3367.
10. Lasithiotakis K, Leiter U, Meier F, Eigentler T, Metzler G, Moehrle M, Breuninger H, Garbe C: Age and gender are significant independent predictors of survival in primary cutaneous melanoma. Cancer 2008, 112(8):1795-1804. (Pubitemid 351536840)
11. Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, Urist MM, Ariyan S, Sussman JJ, Edwards MJ, et al: Gender-related differences in outcome for melanoma patients. Ann Surg 2006, 243(5):693-698. discussion 698-700. (Pubitemid 44305591)
12. Mervic L, Leiter U, Meier F, Eigentler T, Forschner A, Metzler G, Bartenjev I, Buttner P, Garbe C: Sex differences in survival of cutaneous melanoma are age dependent: an analysis of 7338 patients. Melanoma Res 2011, 21(3):244-252.
13. Balzi D, Carli P, Giannotti B, Buiatti E: Skin melanoma in Italy: a population-based study on survival and prognostic factors. Eur J Cancer 1998, 34(5):699-704. (Pubitemid 28218947)
14. Mervic L: Time Course and Pattern of Metastasis of Cutaneous Melanoma Differ between Men and Women. PLoS One 2012, 7(3):e32955.
15. Wangefjord S, Manjer J, Gaber A, Nodin B, Eberhard J, Jirstrom K: Cyclin D1 expression in colorectal cancer is a favourable prognostic factor in men but not women in a prospective, population-based cohort study. Biol Sex Differ 2011, 2(1):10.
16. Press OA, Zhang W, Gordon MA, Yang D, Lurje G, Iqbal S, El-Khoueiry A, Lenz HJ: Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer. Cancer Res 2008, 68(8):3037-3042. (Pubitemid 351556305)
17. Berglund G, Elmstahl S, Janzon L, Larsson SA: The Malmo Diet and Cancer Study. Design and feasibility. J Intern Med 1993, 233(1):45-51.
18. Jonsson L, Bergman J, Nodin B, Manjer J, Ponten F, Uhlen M, Jirstrom K: Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmo Diet and Cancer Study. J Transl Med 2011, 9:114.
19. Balch CM, Soong SJ, Bartolucci AA, Urist MM, Karakousis CP, Smith TJ, Temple WJ, Ross MI, Jewell WR, Mihm MC, et al: Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996, 224(3):255-263. discussion 263-256.
20. Garbe C, Buttner P, Bertz J, Burg G, d'Hoedt B, Drepper H, Guggenmoos-Holzmann I, Lechner W, Lippold A, Orfanos CE, et al: Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer 1995, 75(10):2492-2498.
21. Schuchter L, Schultz DJ, Synnestvedt M, Trock BJ, Guerry D, Elder DE, Elenitsas R, Clark WH, Halpern AC: A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group. Ann Intern Med 1996, 125(5):369-375. (Pubitemid 126449706)
22. Callender GG, Egger ME, Burton AL, Scoggins CR, Ross MI, Stromberg AJ, Hagendoorn L, Martin RC II, McMasters KM: Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker. Am J Surg 2011, 202(6):659-664. discussion 664-655.
23. Porter GA, Ross MI, Berman RS, Lee JE, Mansfield PF, Gershenwald JE: Significance of multiple nodal basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy. Ann Surg Oncol 2000, 7(4):256-261. (Pubitemid 30318312)
24. Manjer J, Carlsson S, Elmstahl S, Gullberg B, Janzon L, Lindstrom M, Mattisson I, Berglund G: The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev 2001, 10(6):489-499. (Pubitemid 34048904)
25. Purdue MP, Freeman LE, Anderson WF, Tucker MA: Recent trends in incidence of cutaneous melanoma among US Caucasian young adults. J Invest Dermatol 2008, 128(12):2905-2908.
26. Reed KB, Brewer JD, Lohse CM, Bringe KE, Pruitt CN, Gibson LE: Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota. Mayo Clin Proc 2012, 87(4):328-334.
27. Coelho SG, Hearing VJ: UVA tanning is involved in the increased incidence of skin cancers in fair-skinned young women. Pigment Cell Melanoma Res 2010, 23(1):57-63.
28. Robinson JK, Rigel DS, Amonette RA: Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996. J Am Acad Dermatol 1997, 37(2 Pt 1):179-186. (Pubitemid 27355701)
29. Choi K, Lazovich D, Southwell B, Forster J, Rolnick SJ, Jackson J: Prevalence and characteristics of indoor tanning use among men and women in the United States. Arch Dermatol 2010, 146(12):1356-1361.
30. de Wit NJ, van Muijen GN, Ruiter DJ: Immunohistochemistry in melanocytic proliferative lesions. Histopathology 2004, 44(6):517-541. (Pubitemid 38845098)
31. Lomuto M, Calabrese P, Giuliani A: Prognostic signs in melanoma: state of the art. J Eur Acad Dermatol Venereol 2004, 18(3):291-300. (Pubitemid 38618324)
32. Li N, Mangini J, Bhawan J: New prognostic factors of cutaneous melanoma: a review of the literature. J Cutan Pathol 2002, 29(6):324-340.
33. Gimotty PA, Van Belle P, Elder DE, Murry T, Montone KT, Xu X, Hotz S, Raines S, Ming ME, Wahl P, et al: Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma. J Clin Oncol 2005, 23 (31):8048-8056. (Pubitemid 46657407)
34. Eggermont AM, Spatz A, Lazar V, Robert C: Is ulceration in cutaneous melanoma just a prognostic and predictive factor or is ulcerated melanoma a distinct biologic entity? Curr Opin Oncol 2012, 24(2):137-140.